By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

Icon Bioscience 

1253 Reamwood Avenue

Sunnyvale  California  94089  U.S.A.
Phone: 408-734-8188 Fax: n/a


SEARCH JOBS


Industry
Pharmaceutical






Company News
Icon Bioscience Announces Early Completion Of Patient Enrollment In Its Phase 3 Study Of IBI-10090; Drug Addresses Market Need For Long-Acting Treatment Of Inflammation Post Cataract Surgery 6/30/2014 10:20:23 AM
Icon Bioscience Achieves Key Milestone With IBI-10090 Advancing Through Phase 3 Studies; Drug Targets Medical Need For Long-Acting Treatment Of Inflammation Post Cataract Surgery 5/6/2014 10:24:56 AM
Eye Drug Company Icon Bioscience Raises $15 Million, Seeks More 8/29/2013 8:06:41 AM
Icon Bioscience's Melphalan Intraocular Injection Granted U.S. Orphan Drug Designation for the Treatment of Retinoblastoma 1/3/2013 9:00:32 AM
Icon Bioscience Appoints Murahashi Vice President, Clinical Development 12/7/2011 10:54:45 AM
Icon Bioscience Initiates Phase 2/3 Pivotal Clinical Study of Novel Ophthalmic Drug Candidate 1/5/2010 11:33:47 AM
Icon Bioscience Completes Enrollment in Phase I Study of Novel Ophthalmic Drug Candidate 8/5/2008 8:52:46 AM
//-->